TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 150 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $83,797,841 | -30.9% | 3,984,681 | -19.1% | 1.70% | -34.3% |
Q3 2022 | $121,301,000 | +1.7% | 4,922,941 | 0.0% | 2.59% | -18.6% |
Q2 2022 | $119,283,000 | -6.0% | 4,922,941 | 0.0% | 3.18% | +14.9% |
Q1 2022 | $126,864,000 | -27.2% | 4,922,941 | -12.3% | 2.77% | -9.9% |
Q4 2021 | $174,272,000 | +28.0% | 5,614,428 | 0.0% | 3.07% | +62.9% |
Q3 2021 | $136,150,000 | +66.2% | 5,614,428 | 0.0% | 1.89% | +43.5% |
Q2 2021 | $81,915,000 | -41.6% | 5,614,428 | 0.0% | 1.32% | -37.8% |
Q1 2021 | $140,192,000 | +12.9% | 5,614,428 | +23.2% | 2.11% | +21.7% |
Q4 2020 | $124,225,000 | – | 4,557,867 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |